Degradation studies on biodegradable nanocomposite based on polycaprolactone/polycarbonate (80:20%) polyhedral oligomeric silsesquioxane
- 2 December 2008
- journal article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 91A (3) , 834-844
- https://doi.org/10.1002/jbm.a.32335
Abstract
The development of biocompatible polymers has greatly advanced the field of tissue engineering. Some tissues can be propagated on a nondegradable scaffold. Tissue such as cartilage, however, is a complex tissue in which the chondrocytes require their own synthesized extracellular matrix (ECM) to function. Suitable scaffolds for tissue engineering cartilage should provide mechanical strength and degrade at a similar rate to that of cell growth and ECM production. We have developed a biodegradable nanocomposite based on polycaprolactone and polycarbonate polyurethane (PCU) with an incorporated polyhedral oligomeric silsesquioxane (POSS) (POSS modified Poly(caprolactone/carbonate) urethane/urea). Previous work on POSS incorporated into PCU (POSS‐PCU) has been shown to possess good mechanical strength, elasticity and resistance to degradation. This series of experiments involved exposing this polymer to a selection of accelerated degradative solutions for up to 8 weeks. The samples were analyzed by infra‐red spectroscopy, scanning electron microscopy, X‐ray microanalysis, contact angle analysis, and stress‐strain mechanical analysis. Degradation of hard and soft segments of the nanocomposite was evident by infra‐red spectroscopy in all conditioned samples. POSS nanocage degradation was evident in some oxidative/peroxidative systems accompanied by gross changes in surface topography and significant changes in mechanical properties. The hydrophobic polymer became more hydrophilic in all conditions. This biodegradable nanocomposite demonstrated steady degradation with protection of mechanical properties when exposed to hydrolytic enzymes and plasma protein fractions and exhibited more dramatic degradation by oxidation.This pattern may be potentially employed in tissue engineering scaffolds where controlled degradation and retained structural stability of the scaffold is required. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009Keywords
This publication has 41 references indexed in Scilit:
- Compressive properties and degradability of poly(ε‐caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradationJournal of Biomedical Materials Research Part A, 2007
- In vivo biostability of polyether polyurethanes with polyethylene oxide surface‐modifying end groups; resistance to biologic oxidation and stress crackingJournal of Biomedical Materials Research Part A, 2005
- Biostability and macrophage‐mediated foreign body reaction of silicone‐modified polyurethanesJournal of Biomedical Materials Research Part A, 2005
- Enzymatic Degradation of Poly(L‐lactide) and Poly(ε‐caprolactone) Electrospun FibersMacromolecular Bioscience, 2004
- Long-term in vivo biostability of poly(dimethylsiloxane)/poly(hexamethylene oxide) mixed macrodiol-based polyurethane elastomersBiomaterials, 2004
- Scaffolds in tissue engineering bone and cartilageBiomaterials, 2000
- Lifetime Risk from Polyurethane Covered Breast ImplantsEnvironmental Health Perspectives, 1998
- Glass Wool–H2O2/CoCl2 test system for in vitro evaluation of biodegradative stress cracking in polyurethane elastomersJournal of Biomedical Materials Research, 1995
- Human plasma α2‐macroglobulin promotes in vitro oxidative stress cracking of pellethane 2363‐80A: In vivo and in vitro correlationsJournal of Biomedical Materials Research, 1993
- Autooxidative Degradation of Implanted Polyether Polyurethane DevicesJournal of Biomaterials Applications, 1986